Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

MAP2K1 GENE MUTATION

Clinical trials for MAP2K1 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new MAP2K1 GENE MUTATION trials appear

Sign up with your email to follow new studies for MAP2K1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1
Sort by
  • New hope for rare blood vessel disorders: targeted drugs enter trial

    Disease control Recruiting now

    This study tests two targeted drugs (alpelisib and mirdametinib) in 50 people aged 2 and older with vascular malformations—abnormal blood or lymph vessels. Participants receive 48 weeks of treatment based on their genetic mutation type. The goal is to see if these drugs improve e…

    Matched conditions: MAP2K1 GENE MUTATION

    Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control

    Last updated May 17, 2026 09:11 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space